153 related articles for article (PubMed ID: 26376893)
1. PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors.
Yang HP; Meeker A; Guido R; Gunter MJ; Huang GS; Luhn P; d'Ambrosio L; Wentzensen N; Sherman ME
Cancer Causes Control; 2015 Dec; 26(12):1729-36. PubMed ID: 26376893
[TBL] [Abstract][Full Text] [Related]
2. Expressions and significances of TTF-1 and PTEN in early endometrial cancer.
Zhang HM; Fan TT; Li W; Li XX
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
[TBL] [Abstract][Full Text] [Related]
4. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.
Merritt MA; Strickler HD; Einstein MH; Yang HP; Sherman ME; Wentzensen N; Brouwer-Visser J; Cossio MJ; Whitney KD; Yu H; Gunter MJ; Huang GS
Cancer Causes Control; 2016 Jun; 27(6):737-48. PubMed ID: 27125830
[TBL] [Abstract][Full Text] [Related]
5. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL
Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067
[TBL] [Abstract][Full Text] [Related]
6. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
Lacey JV; Mutter GL; Ronnett BM; Ioffe OB; Duggan MA; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer Res; 2008 Jul; 68(14):6014-20. PubMed ID: 18632658
[TBL] [Abstract][Full Text] [Related]
7. Role of exon 7 PTEN Gene in Endometrial Carcinoma.
Kafshdooz L; Kafshdooz T; Tabrizi AD; Mohaddes Ardabili SM; Akbarzadeh A; Gharesouran J; Ghojazadeh M; Farajnia S
Asian Pac J Cancer Prev; 2015; 16(11):4521-4. PubMed ID: 26107197
[TBL] [Abstract][Full Text] [Related]
8. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
9. Expression of PTEN in endometrial liquid-based cytology.
Di Lorito A; Zappacosta R; Capanna S; Gatta DM; Rosini S; Schmitt FC
Acta Cytol; 2014; 58(5):495-500. PubMed ID: 25358681
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
[TBL] [Abstract][Full Text] [Related]
11. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
13. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
14. Localized Endometrial Proliferations of Pregnancy are Clonal Glandular Outgrowths Characterized by PTEN Loss and PIK3CA Pathogenic Variants.
Wepy C; Chapel DB; Mutter GL; Quade BJ; Nucci MR; Parra-Herran C
Mod Pathol; 2023 Aug; 36(8):100213. PubMed ID: 37172903
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
16. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
17. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.
Mutter GL; Monte NM; Neuberg D; Ferenczy A; Eng C
Cancer Res; 2014 May; 74(10):2796-802. PubMed ID: 24662919
[TBL] [Abstract][Full Text] [Related]
18. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
McCampbell AS; Broaddus RR; Loose DS; Davies PJ
Clin Cancer Res; 2006 Nov; 12(21):6373-8. PubMed ID: 17085648
[TBL] [Abstract][Full Text] [Related]
20. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
